Problems of using artificial intelligence technologies in clinical drug research
The use of artificial intelligence (AI) technologies in clinical trials (CT) of medicines has led to a significant reduction in time and financial costs for the development of new medicines. However, their widespread adoption faces a number of unresolved issues related to data quality, regulation, e...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Russian Academy of Sciences, Siberian Branch Publishing House
2026-03-01
|
| Serija: | Сибирский научный медицинский журнал |
| Teme: | |
| Online dostop: | https://sibmed.elpub.ru/jour/article/view/2725 |
| Oznake: |
Brez oznak, prvi označite!
|